These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
758 related items for PubMed ID: 11982448
41. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A. Int J Geriatr Psychiatry; 2003 Nov; 18(11):1013-20. PubMed ID: 14618553 [Abstract] [Full Text] [Related]
44. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N, Foster RH, Olney R, Plosker GL. Drugs; 2001 Nov; 61(1):111-61. PubMed ID: 11217867 [Abstract] [Full Text] [Related]
45. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia. Dellva MA, Tran P, Tollefson GD, Wentley AL, Beasley CM. Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266 [Abstract] [Full Text] [Related]
46. Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Kinon BJ, Ahl J, Rotelli MD, McMullen E. Am J Emerg Med; 2004 May; 22(3):181-6. PubMed ID: 15138953 [Abstract] [Full Text] [Related]
47. Efficacy of olanzapine: an overview of pivotal clinical trials. Beasley CM, Tollefson GD, Tran PV. J Clin Psychiatry; 1997 May; 58 Suppl 10():7-12. PubMed ID: 9265910 [Abstract] [Full Text] [Related]
48. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. Gomez JC, Crawford AM. J Clin Psychiatry; 2001 May; 62 Suppl 2():6-11. PubMed ID: 11232753 [Abstract] [Full Text] [Related]
49. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME. Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331 [Abstract] [Full Text] [Related]
50. Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data. Detke HC, Zhao F, Witte MM. BMC Psychiatry; 2012 May 30; 12():51. PubMed ID: 22646847 [Abstract] [Full Text] [Related]
51. Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis. Paris G, Bighelli I, Deste G, Siafis S, Schneider-Thoma J, Zhu Y, Davis JM, Vita A, Leucht S. Schizophr Res; 2021 Mar 30; 229():3-11. PubMed ID: 33607608 [Abstract] [Full Text] [Related]
52. Intramuscular aripiprazole in the acute management of psychomotor agitation. De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, De Persis S, Piazzi G, Simonetti A, Telesforo CL, Sciarretta A, Caccia F, Gentile G, Kotzalidis GD, Girardi P. Pharmacotherapy; 2013 Jun 30; 33(6):603-14. PubMed ID: 23505124 [Abstract] [Full Text] [Related]
53. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW. J Psychiatr Pract; 2006 Mar 30; 12(2):103-8. PubMed ID: 16728906 [Abstract] [Full Text] [Related]
54. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Tollefson GD, Sanger TM, Beasley CM, Tran PV. Biol Psychiatry; 1998 Jun 01; 43(11):803-10. PubMed ID: 9611669 [Abstract] [Full Text] [Related]
55. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J. Clin Ther; 2003 Feb 01; 25(2):530-41. PubMed ID: 12749512 [Abstract] [Full Text] [Related]
56. [New formulations of olanzapine in the treatment of acute agitation]. Bartkó G. Neuropsychopharmacol Hung; 2006 Dec 01; 8(4):171-8. PubMed ID: 17211052 [Abstract] [Full Text] [Related]
57. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia. Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, Ye M, Huang J, Zhu S, Wang G, Zhang Q, Zheng H, Zhang L, Wang B, Zhou J, Zhao JP. Int Clin Psychopharmacol; 2012 Mar 01; 27(2):107-13. PubMed ID: 22233697 [Abstract] [Full Text] [Related]
58. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia. Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, Deng H, Li K, Gao C, Wang X, Vanderburg D, Pan S, Tang H, Shu L, Karayal ON. J Clin Psychopharmacol; 2013 Apr 01; 33(2):178-85. PubMed ID: 23422376 [Abstract] [Full Text] [Related]
59. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine. Kinon BJ, Basson BR, Gilmore JA, Malcolm S, Stauffer VL. J Clin Psychiatry; 2000 Nov 01; 61(11):833-40. PubMed ID: 11105736 [Abstract] [Full Text] [Related]
60. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. Am J Psychiatry; 2002 Feb 01; 159(2):255-62. PubMed ID: 11823268 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]